AYAysun Erdem Yaman

Aysun Erdem Yaman

*This is an algorithmically generated author record based on publicly available information.

Aysun Erdem Yaman has a total of 185 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Antiplatelet or Anticoagulant Therapy for Abdominal Aortic Aneurysms: Growth and Clinical Outcomes

    by Aysun Erdem Yaman

    Background: Intraluminal thrombi in the abdominal aortic aneurysms (AAA) were dem- onstrated to increase aneurysm growth. The effect of treatments on thrombus reduction upon AAA enlargement and clinical endpoints is uncertain Therefore, this study aimed to investigate the effect of antiplatelet and anticoagulant therapy on AAA growth and clinical outcomes. Method: A total of 357 patients with AAAs were enrolled in this study. They were divided into 2 groups based on their medical therapies. Patients on antiplatelet and anticoagu- lant therapy were assigned to group 1 (n = 234) and group 2 (n = 92), respectively. Results: The greatest reduction in thrombus diameter change was observed in patients with anticoagulant therapy (group 1, -2.26 mm; group 2, -8.16 mm; P = .001). The greatest aneurysmal enlargement was found in patients with antiplatelet therapy. There was less AAA progression with anticoagulant therapy than with the other therapy (group 1, 2.08 mm; group 2, 1.31 mm P = .027. The more operational need was observed in patients with antiplatelet therapy than in patients with anticoagulant therapy (group 1 67, group 2 16, P = .036) Conclusion: In our study, it was revealed that anticoagulant therapy has been associated with decreased thrombus diameter and less aneurysmal enlargement compared with antiplatelet therapy. Furthermore, this beneficial effect on the thrombus size and aneu- rysmal diameter decreased the operational need in patients with anticoagulant therapy.


  • Open Access

    Effects of Vitamin D Levels on Long-Term Coronary Events in Patients with Proven Coronary Artery Disease: Six-Year Follow-Up

    by Aysun Erdem Yaman, Ufuk Sadık Ceylan

    Although some clinical studies have claimed that low-dose vitamin D (Vit-D) increases the risk of long-term cardiac events, in others, no association was found. To better understand the impact of Vit-D levels on long-term cardiac events in coronary artery disease patients, this study was designed. There were 408 patients with coronary artery disease (CAD). The patients were separated into three groups based on their Vit-D levels: group 1 had levels below 10 ng/mL, group 2 had levels between 10 and 20, and group 3 had levels above 20 ng/mL. Six years were spent monitoring the patients for non-fatal MI, death, vascular revascularization, and stable course data. Mortality was found to be similar between groups (group 1: 24.5%; group 2: 13.8%; group 3: 17.4%; p > 0.05). In group 3, 47.8% of the patients did not experience any cardiac event, while 28.7% in group 2 and 27.6% in group 1 did not experience any cardiac event, and these values were found to be significant in favor of group 3 (p = 0.006). Group 3 was found to have considerably lower rates of non-ST-elevated myocardial infarction (non-STEMI) and unstable angina (UA) than the other groups did (group 1: 49%; group 2: 38%; group 3: 27%; p = 0.001). In conclusion, although vitamin D deficiency does not accompany an increase in mortality, it is associated with an increase in non-STEMI and UA in patients who have previously been diagnosed with CAD.


  • VDBP and VDR Mutations May Cause In-Stent Restenosis

    by Deniz Kiraç, Aysun Erdem Yaman, Hazal Gezmi̇ş, Kemal Yeşi̇lÇi̇mEn, Tuba Avcilar, İlTer Güney, Elif Çiğdem Altunok, Gülşah Koç, Rabican Akkanat, Turgay İşBi̇r

    Objective: In-stent restenosis (ISR) is the narrowing of a stented coronary artery lesion. A considerable number of patients undergoing percutaneous coronary intervention (PCI) are affected by ISR. The predominant mechanism in the development of ISR is an inflammatory response to vessel wall injury during PCI. Vitamin D is reported to have anti-inflammatory properties, so it may also be related with ISR. Therefore, in this study the relationship between vitamin D receptor (VDR), vitamin D binding protein (VDBP) gene variations and ISR were investigated. Methods: Fifty-eight ISR patients who have chest pain, underwent angiography and were found to have restenosis in the previously inserted stent were included in the patient group and thirty-five patients who have chest pain and were not found to have restenosis in their previous stent in coronary angiography were included in the control group. rs7041 and rs4588 variations in VDBP; rs1544410 and rs2228570 variations in VDR were investigated by real-time polymerase chain reaction (RT-PCR). Results were evaluated statistically. Results: The CC genotype of rs2228570 variation of VDR and the CA genotype of rs4588 variation of VDBP were found statistically high in patient group. rs7041 variation was found statistically high in patients who had myocardial infarction history before stent implantation. Additionally, it was demonstrated that vitamin D deficiency (vitamin D level

  • Kalp Ekibi Gözüyle Kalp Kapak Hastalıkları

    by Kemal Emrecan Parsova, Nurşen Keleş, Aysel Yağmur, Cemil İzGi, Ayşe Gül Ağırman, Sinan Şahin, Altuğ Ösken, Aydın Yıldırım, Esra Poyraz, Dilek Aslan Kutsal, et al.

    Belirli aralıklarla güncellenen, ayrıntılı ve iyi tanımlanmış kapak hastalıkları kılavuzlarına rağmen, kalp kapak hastalıklarının teşhisi, takip stratejileri ve doğru zamanda uygun tedavi yöntemlerinin multidisipliner kalp takımları tarafından yönetilmemesi yanlış tanılara, kapak hastalığının cerrahi veya perkütan girişim ile tedavisinde gecikmelere sebebiyet vermektedir. Bu tür istenmeyen sonuçları en aza indirmek için, özel olarak yapılandırılmış tüm tanı, takip ve tedavi süreçlerinde belirlenmiş standartları olan; kapak hastalıkları alanında uzmanlaşmış farklı disiplinlerden birçok klinisyenin görev aldığı, ayaktan hasta takibi ile birlikte yatan hasta tedavi süreçlerini de yöneten; bununla birlikte eğitim ve öğretim faaliyetlerinide sürdüren “Kalp Kapak Klinikleri” bulunmaktadır. Uluslararası kalp kapak hastalıkları tedavi kılavuzları, bu uzman kalp kapak kliniği konseptini, “Kalp Kapak Mükemmelliyet Merkezi” veya “Kalp Kapak Merkezi” olarak tanımlamaktadır. Dr.Siyami Ersek Göğüs Kalp ve Damar Cerrahisi Eğitim ve Araştırma Hastanesi de ülkemizde bu tanımlamalara uyan az sayıdaki merkezlerden en köklü ve büyük olanlarındandır.

  • COX-1, COX-2 and CYP2C19 variations may be related to cardiovascular events due to acetylsalicylic acid resistance

    by Deniz Kirac, Aysun Erdem Yaman, Tansu Doran, Mujgan Mihmanli, Elif Cigdem Keles

    Background In some stent implanted patients, cardiovascular events (CE) may occur. Acetylsalicylic acid (ASA) is routinely administered to these patients in order to prevent the occurrence of CE. CE may be related to gene variations which cause ASA resistance (AR). Therefore, it was aimed to investigate the relationship between COX-1, COX-2, CYP2C9 and CYP2C19 variations with CE due to AR. Materials and results Seventy-four stent implanted patients, using 100 mg of ASA per day during five years were enrolled into the study. Following stent implantation, thirty-eight patients who had a CE within five years due to AR and 36 patients without CE were enrolled in patient and control group, respectively. AR was confirmed by platelet aggregation testing. After DNA isolation from blood; COX-1, COX-2, CYP2C19 and CYP2C9 variations were investigated with real-time polymerase chain reaction. At the end of this study, heterozygous genotype of COX-1 was found statistically high in patients whereas heterozygous genotype of CYP2C19*17 was found statistically high in controls. The presence of C and G allele in COX-1 and COX-2 were found statistically high in patients, respectively. The presence of T allele in CYP2C19*17 was found statistically high in controls. Heterozygous genotype of COX-1 variation was found statistically high in patients who have AR. Additionally heterozygous genotype of CYP2C19*17 was found statistically high in patients who have low thrombosis risk. Conclusions COX-1 and COX-2 gene mutations may increase the risk of CE due to AR whereas CYP2C19*17 may have a protective effect in this process.


  • The Relationship Between Warfarin Resistance and CYP2C9*2 and CYP2C9*3 Variatıons

    by Deniz Kıraç, Aysun Erdem Yaman, Tansu Doran, Elif Çiğdem Altunok

  • Open Access

    Transfemoral aortic valve implantation in the case of pre-existing mitral prosthesis and pure aortic regurgitation: A case report

    by Aysun Erdem, Aycan Esen Zencirci, Kivilcim Ozden, Sait Terzi

    Transcatheter aortic valve replacement (TAVR) is recommended in patients with severe aortic stenosis who have high surgical risk. However, in the pre-existing mechanical mitral valve prosthesis and natural pure aortic regurgitation, TAVR is relatively contraindicated. In this report, we described one case of TAVR with native aortic regurgitation in the presence of mechanical mitral valve prosthesis. A 64-year-old man with a medical history of mitral valve replacement had severe dyspnea and was symptomatic even at rest for 3 mo. His echocardiography showed severe native pure aortic regurgitation. His euroscore was 15. A TAVR procedure with an evolut R was planned. A 34 mm evolut R was placed by transesophageal echocardiography. The mitral prosthesis was functioning normally, and mild-moderate paravalvular leakage was evident by transesophageal echocardiography. The patient recovered without any complication. At 1 mo follow up, the patient was well, and no paravalvular leakage was noted. TAVR for pure aortic regurgitation in the presence of prosthetic mitral valve can be a safe procedure.

  • Open Access

    Clinical usefulness of red cell distribution width to angiographic severity and coronary stent thrombosis

    by Aysun Erdem, Ufuk Sadik Ceylan, Aycan Esen, Ertugrul Zencirci, Birol Topcu, Kivilcim Ozden, Selcuk Yazici, Sait Terzi, Ayse Emre, Kemal Yesilcimen

    Clinical usefulness of red cell distribution width to angiographic severity and coronary stent thrombosis Aysun Erdem,1 Ufuk Sadik Ceylan,1 Aycan Esen,1 Ertugrul Zencirci,2 Birol Topcu,3 Kivilcim Ozden,1 Selcuk Yazici,1 Sait Terzi,1 Ayse Emre,1 Kemal Yesilcimen1 1Department of Cardiology, Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey; 2Department of Cardiology, Acibadem Hospital Maslak, Istanbul, Turkey; 3Department of Biostatistics, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey Background: Red cell distribution width (RDW) is a quantitative measurement and shows heterogeneity of red blood cell size in peripheral blood. RDW has recently been associated with cardiovascular events and cardiovascular diseases, and it is a novel predictor of mortality. In this study, we aimed to evaluate the clinical usefulness of measuring RDW in patients with coronary stent thrombosis.Patients and methods: We retrospectively reviewed 3,925 consecutive patients who presented with acute coronary syndrome and who underwent coronary angiography at the Siyami Ersek Hospital between May 2011 and December 2013. Of the 3,925 patients, 73 patients (55 males, mean age 59±11 years, 55 with ST elevated myocardial infarction) with stent thrombosis formed group 1. Another 54 consecutive patients who presented with acute coronary syndrome (without coronary stent thrombosis, 22 patients with ST elevated myocardial infarction, 44 males, mean age 54±2 years) and underwent percutaneous coronary intervention in May 2011 formed group 2. Data were collected from all groups for 2 years. The RDW values were calculated from patients 1 month later at follow-up. Syntax scores were calculated for all the patients. The patients were also divided as low syntax score group and moderate–high syntax score group.Results: The patients in group 1 with stent thrombosis had significantly higher RDW level (13.85) than the patients in group 2 without stent thrombosis (12) (P


  • Relation of contrast nephropathy to adverse events in pulmonary emboli patients diagnosed with contrast CT

    by Selçuk Yazıcı, Tuncay Kırış, Ayşe Emre, Ufuk S. Ceylan, Şükrü Akyüz, Ahmet O. Uzun, Recep Hacı, Sait Terzi, Aysun Erdem, Kemal Yeşilçimen


  • PP-060 Relation of the Worsening Renal Function with the Thirty-Day Mortality in Patients with the Non ST-Segment Elevation Myocardial Infarction

    by Selçuk Yazıcı, Ayşe Emre, Ufuk Sadık Ceylan, Aysun Erdem, Sait Terzi, Şükrü Akyüz, Adnan Kaya, Cevdet Dönmez, Zehra Antep, Emrah Bozbeyoğlu, et al.